查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827745

2025年全球關節痛注射市場報告

Joint Pain Injections Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，關節疼痛注射劑市場規模強勁成長，從2024年的56億美元成長到2025年的61.2億美元，複合年成長率為9.3%。預測期內的成長可歸因於人口老化加劇、關節炎盛行率上升、全球健康舉措、醫療保健數位化以及人們對慢性疼痛管理的認知不斷提高。

預計未來幾年關節疼痛注射市場將快速成長，到2029年將達到97.7億美元，複合年成長率為12.4%。預測期內的成長可歸因於遠端醫療服務的擴展、個人化疼痛管理、病患教育和賦能、永續的醫療保健實踐以及營養支持。預測期內的主要趨勢包括再生醫學、個人化疼痛管理、創新注射材料、復健技術和人工智慧 (AI) 增強型注射。

關節疼痛注射透過減輕發炎和不適來發揮作用，通常直接注射到關節中以緩解疼痛。關節疼痛很常見，尤其是在老年人和已有疾病的人群中。關節炎等以疼痛和發炎為特徵的疾病常常會引起關節疼痛。關節疼痛注射是一種非手術方法，可以快速緩解關節疼痛和發炎。

用於治療關節疼痛的主要注射類型包括類固醇關節注射、透明質酸注射、富血小板血漿 (PRP) 注射、胎盤組織基質 (PTM) 注射以及其他各種注射。類固醇關節注射，也稱為皮質類固醇注射，是一種用於治療關節疼痛的抗發炎藥物。它們對減輕發炎性關節炎（例如類風濕性關節炎）的發炎特別有效。關節疼痛注射可注射到各種關節，包括髖關節、膝關節、踝關節、肩關節、肘關節和脊椎的小關節。這些注射劑通常可在醫院藥局、零售藥局和線上藥局購買。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供關節痛注射劑市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的關節痛注射劑市場細分、市場趨勢和商機，以及您在關節痛注射劑行業取得成功所需的數據。本關節痛注射劑市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為12.4%，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。美國可能會直接感受到這種影響，因為透明質酸製劑和皮質類固醇混懸液的供應鏈中斷，這些藥物主要來自瑞士和日本等主要地區，這可能導致骨關節炎治療延誤和整形外科疼痛管理成本增加。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響也可能波及更廣泛的領域。

關節炎和肌肉骨骼疾病的日益普及預計將推動關節痛注射市場的成長。肌肉骨骼疾病是全球造成殘疾的主要原因，其中腰痛被確定為160個國家中最常見的殘疾原因。疼痛患者經常接受注射來緩解疼痛和控制發炎。例如，2023年6月，澳洲政府機構澳洲健康與福利研究所報告稱，類風濕性關節炎佔總疾病負擔的2.0%，佔肌肉骨骼疾病相關總疾病負擔的16%。 2022年，報告的死亡人數為1,322人，相當於每10萬人中有5.1人死亡，佔所有死亡人數的0.7%。因此，關節炎和肌肉骨骼疾病的日益普及正在推動關節痛注射市場的發展。

預計慢性疼痛發病率的上升將推動關節痛注射市場的未來成長。慢性疼痛的特徵是持續性或長期不適，持續時間較長，通常至少持續三到六個月，或超過預期的癒合期。關節痛注射通常用於治療慢性疼痛，尤其是當它與骨關節炎、類風濕性關節炎等肌肉骨骼疾病和其他關節相關問題有關時。例如，2022 年 9 月，世界衛生組織 (WHO) 在 2022 年重點報告中報告中報告稱，非傳染性疾病 (NCD) 或慢性疾病將導致 4,100 萬人死亡，佔全球整體的 74%。因此，慢性疼痛發生率的上升正在推動關節痛注射市場的成長。

關節疼痛注射市場的一個顯著趨勢是越來越注重新產品開發。該領域的主要企業正在積極進行新產品創新，以滿足消費者需求並鞏固其市場地位。例如，總部位於英國的治療性水凝膠製造商Contura International Ltd.於2021年9月推出了Arthrosamid。 Arthrosamid是一種用於治療膝關節骨關節炎的創新水凝膠注射劑，它利用不可生物分解的水凝膠技術，為膝關節骨關節炎疼痛提供強效、持久、安全且微創的治療方案。

關節痛注射市場的主要企業正致力於開發創新產品，例如優先考慮患者便利性的單次注射劑型。單次注射劑型是一種給藥系統，旨在透過單次注射給藥固定劑量的藥物，無需多次注射，並能長期持續治療效果。例如，2024年7月，韓國化學公司LG化學有限公司在中國推出了Synovian，這是一種治療膝關節骨關節炎的新型藥物，採用便捷的單次注射劑型。該產品旨在佔領一個價值約2000億韓元（約1.5億美元）的巨大市場。該產品採用專有技術開發，專注於以最少的給藥努力提供有效的緩解，展現了滿足患者需求的創新。

2022年11月，印度製藥公司Biocon Biologics Limited以33.3億美元收購了Viatris Inc.的生物相似藥業務。此次收購將使Biocon能夠利用Viatris豐富的經驗和在全球市場的穩固地位，從而改善全球患者獲得重要治療藥物的管道。這項策略性措施預計將增強Biocon的生物相似藥產品組合，包括用於治療類風濕性關節炎等免疫介導疾病的Adalimumab皮下注射用BS。 Viatris Inc.是一家總部位於美國的醫療保健公司，提供關節疼痛治療服務。

關節痛注射市場的主要公司包括工業株式會社、Flexion Therapeutics Inc.、Zimmer Biomet Holdings Inc.、Sanofi SA、Anika Therapeutics Inc.、Abbvie Inc.、Bioventus Inc.、禮來公司、Ferring Pharmaceuticals Inc.、輝瑞公司、Teva Pharmaceutical Limited、強生服務有限公司、默克公司、葛蘭素史克公司、諾華公司、GlaxoSmithKline Plc公司、Astra Zeneca控股公司、百時美施貴寶公司、勃林格殷格翰國際有限公司、武田製藥有限公司、工業、第一三共株式會社、衛材株式會社公司有限公司、拜耳公司、安斯泰來製藥公司、第一三共株式會社、衛材株式會社公司有限公司、EisaiAstellas生公司、益普生普生公司、益普生普斯Ltd.、邁蘭公司、太陽製藥工業有限公司、Wockhardt Ltd. Zydus Lifesciences Limited 等。

2024 年，北美是關節痛注射市場最大的地區。關節痛注射市場分析報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

關節痛注射市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

關節痛注射市場包括硬膜外類固醇注射、小關節注射、關節內粘稠補充療法注射、皮質類固醇注射和透明質酸注射的銷售。該市場的價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球關節痛注射：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球關節疼痛注射市場：成長率分析
  • 全球關節痛注射市場表現：規模與成長，2019-2024
  • 全球關節痛注射市場預測：規模與成長，2024-2029年，2034年
  • 全球關節痛注射劑：總目標市場（TAM）

第6章 市場細分

  • 全球關節痛注射市場（按注射類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 類固醇關節注射
  • 玻尿酸注射
  • 富血小板血漿（PRP）注射
  • 胎盤組織基質（PTM）注射
  • 其他類型的注射
  • 全球關節疼痛注射市場（按關節類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 髖關節
  • 膝蓋和腳踝
  • 肩膀和肘部
  • 脊椎椎間關節
  • 其他關節類型
  • 全球關節痛注射劑市場：按分銷管道、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 全球關節痛注射市場：細分：類固醇關節注射（按注射類型），實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 皮質類固醇注射
  • 聯合類固醇注射
  • 全球關節痛注射市場：透明質酸注射細分市場（按注射類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 單劑量透明質酸注射
  • 多次注射玻尿酸
  • 全球關節痛注射市場：富血小板血漿 (PRP) 注射細分（按注射類型）、實際及預測（2019-2024 年、2024-2029 年、2034 年）
  • 自我 PRP 注射
  • 同種異體PRP注射
  • 全球關節痛注射市場：細分：胎盤組織基質 (PTM) 注射（按注射類型），實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 羊水注射
  • 胎盤細胞注射
  • 全球關節痛注射市場：按注射類型細分，其他注射類型（按注射類型），實際和預測，2019-2024 年，2024-2029 年，2034 年
  • 骨髓抽吸濃縮液（BMAC）注射
  • 幹細胞注射
  • 基因改造細胞注射

第7章 區域和國家分析

  • 全球關節痛注射市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球關節痛注射市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 關節痛注射市場：競爭格局
  • 關節痛注射市場：公司簡介
    • Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Abbvie Inc.
  • Bioventus Inc.
  • Eli Lilly and Company
  • Ferring Pharmaceuticals Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Limited
  • Johnson & Johnson Services Ltd.
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Roche Holding AG
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Takeda Pharmaceutical Company Limited

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年關節痛注射市場：提供新機會的國家
  • 2029年關節痛注射市場：細分市場帶來新機會
  • 2029年關節痛注射市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21691u

Joint pain injections serve to reduce inflammation and discomfort, typically administered directly into the joint to alleviate pain. Joint pain is a common occurrence, particularly among the elderly or individuals with pre-existing medical conditions or disorders. Conditions such as arthritis, characterized by pain and inflammation, often contribute to joint pain. Joint pain injections offer a non-surgical approach to quickly relieve joint pain and inflammation.

The primary types of injections for joint pain include steroid joint injections, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, and various others. Steroid joint injections, also known as corticosteroid injections, are anti-inflammatory medications used to treat joint pain. They are particularly effective in reducing inflammation in individuals with conditions like rheumatoid arthritis and other forms of inflammatory arthritis. Joint pain injections are applied to various types of joints, including the hip joint, knee and ankle joints, shoulder and elbow joints, facet joints of the spine, and others. These injections are commonly distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The joint pain injections market research report is one of a series of new reports from The Business Research Company that provides joint pain injections market statistics, including joint pain injections industry global market size, regional shares, competitors with a joint pain injections market share, detailed joint pain injections market segments, market trends and opportunities, and any further data you may need to thrive in the joint pain injections industry. This joint pain injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The joint pain injections market size has grown strongly in recent years. It will grow from $5.6 billion in 2024 to $6.12 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increased aging population, arthritis prevalence, global health initiatives, healthcare digitalization, increasing awareness of chronic pain management.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $9.77 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to expansion of telehealth services, personalized pain management, patient education and empowerment, sustainable healthcare practices, nutritional support. Major trends in the forecast period include regenerative medicine, personalized pain management, innovative injection materials, rehabilitation technologies, artificial intelligence ai-enhanced injections.

The forecast of 12.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for hyaluronic acid formulations and corticosteroid suspension solutions, sourced from key regions such as Switzerland and Japan, which could lead to delayed osteoarthritis treatments and increased costs for orthopedic pain management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of arthritis and musculoskeletal disorders is expected to drive the growth of the joint pain injections market. Musculoskeletal disorders are the leading cause of disability globally, with low back pain identified as the most common cause of impairment in 160 countries. Patients often seek injections for pain relief and to manage inflammatory conditions. For example, in June 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that rheumatoid arthritis accounted for 2.0% of the total disease burden and 16% of the overall burden of disease related to musculoskeletal conditions. In 2022, it resulted in 1,322 deaths, equating to 5.1 deaths per 100,000 people, which represented 0.7% of all deaths. Therefore, the rising prevalence of arthritis and musculoskeletal disorders is driving the joint pain injections market.

The rising incidence of chronic pain is anticipated to drive the growth of the joint pain injections market in the future. Chronic pain is characterized by persistent or long-lasting discomfort that continues for an extended duration, typically defined as lasting at least three to six months or beyond the expected healing time. Joint pain injections are commonly utilized to manage chronic pain, particularly when it is linked to musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, or other joint-related issues. For example, in September 2022, the World Health Organization (WHO) reported in its 2022 Highlights that there were 41 million deaths, accounting for 74% of all fatalities due to noncommunicable diseases (NCDs) or chronic diseases globally each year. Consequently, the increase in the incidence of chronic pain is propelling the growth of the joint pain injections market.

A prominent trend in the joint pain injections market is the focus on new product development. Major companies in this sector are actively engaged in innovating new products to meet consumer demand and enhance their market position. For instance, Contura International Ltd., a UK-based manufacturer of therapeutic hydrogels, introduced Arthrosamid in September 2021. Arthrosamid, an innovative hydrogel injection for knee osteoarthritis, utilizes non-biodegradable hydrogel technology, providing a potent, long-lasting, secure, and minimally intrusive treatment for knee osteoarthritis pain.

Leading companies in the joint pain injections market are concentrating on developing innovations such as single-injection formulations, which prioritize patient convenience. A single-injection formulation is a type of drug delivery system designed to deliver a specific dose of medication in a single injection, offering sustained therapeutic effects over an extended period without the need for multiple doses. For example, in July 2024, LG Chem Ltd., a chemicals company based in South Korea, introduced Synovian, a new treatment for knee osteoarthritis in China that features a convenient single-injection formulation, making it the first of its kind in the country. The product aims to capture a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed using proprietary technology, it demonstrates innovation in meeting patient needs, focusing on providing effective relief with minimal administration effort.

In November 2022, Biocon Biologics Limited, a pharmaceutical company based in India, acquired the biosimilars business from Viatris Inc. for $3.33 billion. This acquisition enables Biocon to utilize Viatris' extensive experience and established presence in the global market, improving access to critical therapies for patients around the world. This strategic move is anticipated to enhance its biosimilars portfolio, including Adalimumab BS for subcutaneous injection, which is indicated for immune-related diseases like rheumatoid arthritis. Viatris Inc. is a healthcare company based in the US that offers joint pain medications.

Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The joint pain injections market consists of sales of epidural steroid injections, facet joint injections, viscosupplementation injections, corticosteroid injections and hyaluronic acid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Joint Pain Injections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on joint pain injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for joint pain injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The joint pain injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Injection: Steroid Joint Injection; Hyaluronic Acid Injections; Platelet-Rich Plasma (PRP) Injections; Placental Tissue Matrix (PTM) Injections; Other Type Of Injections
  • 2) By Joint Type: Hip Joint; Knee And Ankle; Shoulder And Elbow; Facet Joints Of The Spine; Other Joint Types
  • 3) By Distribution channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Subsegments:
  • 1) By Steroid Joint Injection: Corticosteroid Injections; Combination Steroid Injections
  • 2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections; Multi-Dose Hyaluronic Acid Injections
  • 3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections; Allogeneic PRP Injections
  • 4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections; Placental Derived Cell Injections
  • 5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections; Stem Cell Injections; Genetically Engineered Cell Injections
  • Companies Mentioned: Seikagaku Corporation; Flexion Therapeutics Inc.; Zimmer Biomet Holdings Inc.; Sanofi S.A.; Anika Therapeutics Inc.; Abbvie Inc.; Bioventus Inc.; Eli Lilly and Company; Ferring Pharmaceuticals Inc.; Pfizer Inc.; Teva Pharmaceutical Industries Limited; Johnson & Johnson Services Ltd.; Merck & Co. Inc.; GlaxoSmithKline plc; Novartis AG; AstraZeneca plc; Roche Holding AG; Bristol-Myers Squibb Company; Boehringer Ingelheim International GmbH; Takeda Pharmaceutical Company Limited; Bayer AG; Astellas Pharma Inc.; Daiichi Sankyo Company Limited; Eisai Co. Ltd.; Ipsen SA; Mallinckrodt Pharmaceuticals Ltd.; Mylan N.V.; Sun Pharmaceutical Industries Ltd.; Wockhardt Ltd.; Zydus Lifesciences Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Joint Pain Injections Market Characteristics

3. Joint Pain Injections Market Trends And Strategies

4. Joint Pain Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Joint Pain Injections Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Joint Pain Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Joint Pain Injections Market Growth Rate Analysis
  • 5.4. Global Joint Pain Injections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Joint Pain Injections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Joint Pain Injections Total Addressable Market (TAM)

6. Joint Pain Injections Market Segmentation

  • 6.1. Global Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Steroid Joint Injection
  • Hyaluronic Acid Injections
  • Platelet-Rich Plasma (PRP) Injections
  • Placental Tissue Matrix (PTM) Injections
  • Other Type Of Injection
  • 6.2. Global Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hip Joint
  • Knee And Ankle
  • Shoulder And Elbow
  • Facet Joints Of The Spine
  • Other Joint Types
  • 6.3. Global Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.4. Global Joint Pain Injections Market, Sub-Segmentation Of Steroid Joint Injection, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Corticosteroid Injections
  • Combination Steroid Injections
  • 6.5. Global Joint Pain Injections Market, Sub-Segmentation Of Hyaluronic Acid Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Hyaluronic Acid Injections
  • Multi-Dose Hyaluronic Acid Injections
  • 6.6. Global Joint Pain Injections Market, Sub-Segmentation Of Platelet-Rich Plasma (PRP) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autologous PRP Injections
  • Allogeneic PRP Injections
  • 6.7. Global Joint Pain Injections Market, Sub-Segmentation Of Placental Tissue Matrix (PTM) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amniotic Fluid Injections
  • Placental Derived Cell Injections
  • 6.8. Global Joint Pain Injections Market, Sub-Segmentation Of Other Types of Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Marrow Aspirate Concentrate (BMAC) Injections
  • Stem Cell Injections
  • Genetically Engineered Cell Injections

7. Joint Pain Injections Market Regional And Country Analysis

  • 7.1. Global Joint Pain Injections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Joint Pain Injections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Joint Pain Injections Market

  • 8.1. Asia-Pacific Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Joint Pain Injections Market

  • 9.1. China Joint Pain Injections Market Overview
  • 9.2. China Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Joint Pain Injections Market

  • 10.1. India Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Joint Pain Injections Market

  • 11.1. Japan Joint Pain Injections Market Overview
  • 11.2. Japan Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Joint Pain Injections Market

  • 12.1. Australia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Joint Pain Injections Market

  • 13.1. Indonesia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Joint Pain Injections Market

  • 14.1. South Korea Joint Pain Injections Market Overview
  • 14.2. South Korea Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Joint Pain Injections Market

  • 15.1. Western Europe Joint Pain Injections Market Overview
  • 15.2. Western Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Joint Pain Injections Market

  • 16.1. UK Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Joint Pain Injections Market

  • 17.1. Germany Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Joint Pain Injections Market

  • 18.1. France Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Joint Pain Injections Market

  • 19.1. Italy Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Joint Pain Injections Market

  • 20.1. Spain Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Joint Pain Injections Market

  • 21.1. Eastern Europe Joint Pain Injections Market Overview
  • 21.2. Eastern Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Joint Pain Injections Market

  • 22.1. Russia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Joint Pain Injections Market

  • 23.1. North America Joint Pain Injections Market Overview
  • 23.2. North America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Joint Pain Injections Market

  • 24.1. USA Joint Pain Injections Market Overview
  • 24.2. USA Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Joint Pain Injections Market

  • 25.1. Canada Joint Pain Injections Market Overview
  • 25.2. Canada Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Joint Pain Injections Market

  • 26.1. South America Joint Pain Injections Market Overview
  • 26.2. South America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Joint Pain Injections Market

  • 27.1. Brazil Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Joint Pain Injections Market

  • 28.1. Middle East Joint Pain Injections Market Overview
  • 28.2. Middle East Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Joint Pain Injections Market

  • 29.1. Africa Joint Pain Injections Market Overview
  • 29.2. Africa Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Joint Pain Injections Market Competitive Landscape And Company Profiles

  • 30.1. Joint Pain Injections Market Competitive Landscape
  • 30.2. Joint Pain Injections Market Company Profiles
    • 30.2.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Joint Pain Injections Market Other Major And Innovative Companies

  • 31.1. Abbvie Inc.
  • 31.2. Bioventus Inc.
  • 31.3. Eli Lilly and Company
  • 31.4. Ferring Pharmaceuticals Inc.
  • 31.5. Pfizer Inc.
  • 31.6. Teva Pharmaceutical Industries Limited
  • 31.7. Johnson & Johnson Services Ltd.
  • 31.8. Merck & Co. Inc.
  • 31.9. GlaxoSmithKline plc
  • 31.10. Novartis AG
  • 31.11. AstraZeneca plc
  • 31.12. Roche Holding AG
  • 31.13. Bristol-Myers Squibb Company
  • 31.14. Boehringer Ingelheim International GmbH
  • 31.15. Takeda Pharmaceutical Company Limited

32. Global Joint Pain Injections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Joint Pain Injections Market

34. Recent Developments In The Joint Pain Injections Market

35. Joint Pain Injections Market High Potential Countries, Segments and Strategies

  • 35.1 Joint Pain Injections Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Joint Pain Injections Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Joint Pain Injections Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer